Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial by Yuhang Zhang et al. Find out more here: https://t.co/lvk5l5BHGq Watch the Video here: https://t.co/RdM8qbDqXj https://t.co/yvDDGusRgH
Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Nov 2020All 8 dated mentions so far are from Nov 2020.
Where it's discussed
-
X / Twitter6 posts
-
YouTube2 videos
-
Facebook2 posts
AI synopsis
What people are saying
The group displays moderate enthusiasm for the study, with posts like 'ESD is effective for early esophageal cancer' and commentary from professionals emphasizing its safety and benefits, using words like 'significantly' and 'safe' to underscore the findings. The tone varies from supportive to informative, reflecting a shared recognition of the article's significance and a keen interest in applying its insights.
Most discussions express support or positive views about the safety and efficacy of combining ESD with radiotherapy based on the study's promising results.
Participants show moderate interest, frequently referencing the treatment method and its benefits, though some simply share the publication's title or links.
Several comments delve into the details of the publication, including mentions of recurrence rates, safety, and potential clinical applications, indicating a deep level of engagement.
The discussions highlight the potential of the combined treatment to influence clinical practice, even as some posts focus on informational content.
Abstract in brief
- This study evaluated whether combining endoscopic submucosal dissection (ESD) with additional radiotherapy improves outcomes for patients with early-stage T1a esophageal squamous cell carcinoma, showing that adding radiotherapy significantly reduced recurrence rates without increasing severe side effects.
- Patients who received radiotherapy after ESD had a 3-year recurrence-free survival rate of 100%, compared to 85.3% for those who only had follow-up, indicating that radiotherapy can help prevent cancer from returning.
- The study also found that large mucosal defects increased the risk of esophageal stenosis, but no severe radiation-related toxicities were observed, suggesting that post-ESD radiotherapy is a safe and effective strategy to prevent recurrence in early ESCC.]
Top posts
Most liked on X and BlueskyAuthor Commentary Yuhang Zhang on "Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial" Watch the Video here: https://t.co/RdM8qbDqXj
Podcast "Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial" by Yuhang Zhang et al. Listen to the Podcast on YouTube: https://t.co/sTvQtVKKvg
Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial by Yuhang Zhang et al. ESD is effective for treating T1a early esophageal squamous cell carcinoma. https://t.co/lvk5l5BHGq https://t.co/nGDAiWLJ5a
RT @endoscopyjrnl: Podcast "Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell…
RT @endoscopyjrnl: Podcast "Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell…
All mentions
Enhancing T1a Esophageal Cancer Treatment with ESD and Radiotherapy
This study evaluates whether combining endoscopic submucosal dissection with radiotherapy improves outcomes for early-stage T1a esophageal squamous cell carcinoma, showing that adding radiotherapy significantly reduced…
Enhanced Treatment of T1a Esophageal Cancer with Endoscopic Dissection and Radiotherapy
This study evaluates combining endoscopic submucosal dissection with radiotherapy for early T1a esophageal squamous cell carcinoma, showing improved 3-year recurrence-free survival and safety.
Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial by Yuhang Zhang et al. ESD is effective for treating T1a early esophageal squamous cell carcinoma. https://t.co/lvk5l5BHGq https://t.co/nGDAiWLJ5a
RT @endoscopyjrnl: Podcast "Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell…
RT @endoscopyjrnl: Podcast "Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell…
Podcast "Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial" by Yuhang Zhang et al. Listen to the Podcast on YouTube: https://t.co/sTvQtVKKvg
Author Commentary Yuhang Zhang on "Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial" Watch the Video here: https://t.co/RdM8qbDqXj
Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial by Yuhang Zhang et al. Find out more here: https://t.co/lvk5l5BHGq Watch the Video here: https://t.co/RdM8qbDqXj https://t.co/yvDDGusRgH
EJ